Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1526 studies found for:    Recruiting | cancer | United States, Texas
Show Display Options
Download search resultsDownload the search results for:
Recruiting | cancer | United States, Texas (1526 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting Importance of Magnetic Resonance Imaging (MRI) in Treating Breast Cancer
Condition: Breast Cancer
Intervention: Procedure: MRI
2 Recruiting TDM1 With Abraxane and Lapatinib for Metastatic HER2 Positive Breast Cancer
Condition: Metastatic Breast Cancer
Interventions: Drug: TDM1;   Drug: Lapatinib;   Drug: Abraxane
3 Recruiting Enzalutamide and Hormone Therapy Before, During, and After Radiation for High Risk Localized Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Enzalutamide;   Drug: Leuprolide acetate;   Radiation: radiation
4 Recruiting Pilot Study of Durvalumab (MEDI4736) in Combination With Vigil™ in Advanced Breast Cancer
Condition: Triple Negative Breast Cancer
Interventions: Biological: Vigil™;   Drug: Durvalumab (MEDI4736)
5 Recruiting Stereotactic Ablative Body Radiation Therapy for Patients With Primary Renal Cancer
Condition: Renal Cancers
Intervention: Radiation: Stereotactic Ablative Radiation Therapy
6 Recruiting A First-in-Man, Phase I Evaluation of A Single Cycle of Prohibitin Targeting Peptide 1 in Patients With Metastatic Prostate Cancer and Obesity
Condition: Prostate Cancer
Intervention: Drug: Prohibitin-TP01
7 Recruiting Arimidex With or Without Faslodex In Postmenopausal Women With HR Positive Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Arimidex with Faslodex;   Drug: Arimidex without Faslodex
8 Recruiting Young-Onset Microsatellite-Stable Colorectal Cancer
Conditions: Colon Cancer;   Rectal Cancer
Interventions: Behavioral: Questionnaires;   Procedure: Blood Draw
9 Recruiting Denosumab for Breast Cancer With Bone Mets
Condition: Breast Cancer
Intervention: Drug: Denosumab
10 Recruiting Nintedanib For HER2-negative Metastatic Inflammatory Breast Cancer (MIBC)
Condition: Breast Cancer
Interventions: Drug: BIBF 1120;   Behavioral: Phone Call
11 Recruiting Feasibility of Short Breast MRI (SBMRI) for Screening Patients at High Risk for Breast Cancer
Condition: Breast Cancer
Interventions: Procedure: Short Breast MRI (SBMRI);   Behavioral: Questionnaire
12 Recruiting MK-3475 for Metastatic Inflammatory Breast Cancer (MIBC)
Condition: Breast Cancer
Interventions: Drug: MK-3475;   Behavioral: Follow Up/Phone Call
13 Recruiting Genomic Testing for Primary Breast Cancer
Condition: Breast Cancer
Interventions: Procedure: Tumor Biopsy;   Other: Breast Cancer Registry
14 Recruiting Phase IIB Neoadjuvant Enzalutamide (ZT) Plus Taxol for Androgen Receptor (AR)-Positive Triple-Negative Breast Cancer (AR+ TNBC)
Condition: Breast Cancer
Interventions: Drug: Enzalutamide;   Drug: Paclitaxel
15 Recruiting Triple-Negative First-Line Study: Neoadjuvant Trial of Nab-Paclitaxel and MPDL3280A, a Pdl-1 Inhibitor in Patients With Triple Negative Breast Cancer
Condition: Breast Cancer
Interventions: Drug: MPDL3280A;   Drug: Nab-paclitaxel
16 Recruiting The Role of Lifestyle Factors in Breast Cancer-Related Outcomes
Condition: Breast Cancer
Interventions: Behavioral: Aerobic Activity;   Behavioral: Dietician Counseling;   Behavioral: Yoga;   Behavioral: Cognitive Behavior Therapy;   Behavioral: Smoking Cessation Counseling;   Behavioral: Questionnaires;   Other: Saliva Samples;   Behavioral: Dietary Assessment;   Procedure: Blood Samples
17 Recruiting Feasibility and Identification of Breast Cancer Patients for Potential Avoidance of Surgery
Condition: Breast Cancer
Intervention: Procedure: Ultrasound-Guided Biopsy
18 Recruiting Pembrolizumab in Combination With Chemotherapy in Frontline Ovarian Cancer
Conditions: Ovarian Cancer;   Metastatic Ovarian Cancer
Interventions: Drug: Carboplatin;   Drug: Paclitaxel;   Drug: Pembrolizumab
19 Recruiting CyberKnife Accelerated Hemilarynx Stereotactic Radiotherapy Study for Early-stage Glottic Larynx Cancer
Condition: Early-stage Glottic Larynx Cancer
Intervention: Radiation: CyberKnife Accelerated Hemilarynx Stereotactic Radiotherapy
20 Recruiting Ramucirumab for Advanced Pre-treated Biliary Cancers
Condition: Biliary Cancer
Intervention: Drug: Ramucirumab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.